» Articles » PMID: 25102699

Research Progress on Synergistic Anti-tumor Mechanisms of Compounds in Traditional Chinese Medicine

Overview
Date 2014 Aug 9
PMID 25102699
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The curative effects of Chinese herbal compounds result from the coordination of numerous natural compounds. We aimed to review the mechanism of action of Traditional Chinese Medicine (TCM) compounds (TCMC), explore the rationality of formulation theory and synergistic effects in TCM compounds, and analyze the effectiveness of drug compatibility of TCMC in molecular biology. This literature review covers the mechanisms of the anti-tumor effects of compounds, and their synergistic antitumor mechanisms. We aim to provide reference for the effective development and use of natural resources and the organic combination of TCM and modern medicine using molecular biology.

Citing Articles

Artificial intelligence-driven identification and mechanistic exploration of synergistic anti-breast cancer compound combinations from L.- Hand.-Mazz. herb pair.

Feng C, Cheng J, Sun M, Qiao C, Feng Q, Fang N Front Pharmacol. 2025; 15():1522787.

PMID: 39840098 PMC: 11747269. DOI: 10.3389/fphar.2024.1522787.


Traditional Chinese Medicine for Breast Cancer: A Review.

Feng R, Li D, Liu X, Zhao X, Wen Q, Yang Y Breast Cancer (Dove Med Press). 2023; 15:747-759.

PMID: 37915543 PMC: 10617532. DOI: 10.2147/BCTT.S429530.


Global Trends in Research of Treatment on Bladder Cancer with Chinese Medicine Monomer from 2000 to 2021: A Bibliometric Analysis.

Li D, Zuo M, Hu X J Oncol. 2022; 2022:3382360.

PMID: 36245973 PMC: 9553534. DOI: 10.1155/2022/3382360.


N-Butanol Extract of Modified You-Gui-Yin Attenuates Osteoclastogenesis and Ameliorates Osteoporosis by Inhibiting RANKL-Mediated NF-κB Signaling.

Zeng Q, Xu R, Ling H, Zhao S, Wang X, Yuan W Front Endocrinol (Lausanne). 2022; 13:925848.

PMID: 35813633 PMC: 9263119. DOI: 10.3389/fendo.2022.925848.


Suppression of human colon tumor by EERAC through regulating Notch/DLL4/Hes pathway inhibiting angiogenesis .

Yuan C, Wu C, Xue R, Jin C, Zheng C J Cancer. 2021; 12(19):5914-5922.

PMID: 34476005 PMC: 8408117. DOI: 10.7150/jca.61581.